人工智能预测早期AMD个体疾病转化
研究纳入495只中度AMD眼,基于每月OCT图像自动分割外层视网膜层、RPE、玻璃膜疣和高反射灶,结合影像、人口学和遗传特征构建机器学习模型预测进展。2年内159眼(32%)进展为晚期AMD,其中114眼进展为CNV、45眼进展为GA;模型区分进展眼与未进展眼的性能CNV为0.68、GA为0.80。
要点
- 模型预测CNV进展性能0.68、GA进展性能0.80。
- 外层视网膜厚度、高反射灶和玻璃膜疣面积是最关键的进展定量特征。
- CNV与GA进展路径的特征模式明显不同,CNV预测标志以玻璃膜疣为中心,GA标志与神经感觉视网膜和年龄相关。
核心结论
- 人工智能结合影像生物标志物自动分析可实现AMD进展的个体化预测。
- 进展路径可能因新生血管型或萎缩型而不同。
研究设计与样本
- 在中度AMD眼中,由独立阅片者基于标准化每月OCT图像诊断进展为CNV新生血管型或GA干性型。
- 通过谱域OCT图像分析获得外层神经感觉层和RPE、玻璃膜疣及高反射灶的自动体积分割。
- 使用影像、人口学和遗传输入特征,开发并验证基于机器学习的预测模型评估进展为晚期AMD的风险。
主要发现
- 共495只眼,159只眼(32%)在2年内进展为晚期AMD,其中114只眼进展为CNV、45只眼进展为GA。
- 预测模型区分进展眼与未进展眼的性能CNV为0.68、GA为0.80。
- 进展的最关键定量特征为外层视网膜厚度、高反射灶和玻璃膜疣面积。
- 转化特征显示新生血管和萎缩路径明显不同的特征性模式。
- CNV的预测标志主要以玻璃膜疣为中心,而GA标志与神经感觉视网膜和年龄相关。
临床怎么用
- 人工智能结合自动影像生物标志物分析可用于AMD进展的个体化预测。
- 进展路径可能因新生血管型或萎缩型而不同。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While millions of individuals show early age-related macular degeneration (AMD) signs, yet have excellent vision, the risk of progression to advanced AMD with legal blindness is highly variable. We suggest means of artificial intelligence to individually predict AMD progression. METHODS: In eyes with intermediate AMD, progression to the neovascular type with choroidal neovascularization (CNV) or the dry type with geographic atrophy (GA) was diagnosed based on standardized monthly optical coherence tomography (OCT) images by independent graders. We obtained automated volumetric segmentation of outer neurosensory layers and retinal pigment epithelium, drusen, and hyperreflective foci by spectral domain-OCT image analysis. Using imaging, demographic, and genetic input features, we developed and validated a machine learning-based predictive model assessing the risk of conversion to advanced AMD. RESULTS: Of a total of 495 eyes, 159 eyes (32%) had converted to advanced AMD within 2 years, 114 eyes progressed to CNV, and 45 to GA. Our predictive model differentiated converting versus nonconverting eyes with a performance of 0.68 and 0.80 for CNV and GA, respectively. The most critical quantitative features for progression were outer retinal thickness, hyperreflective foci, and drusen area. The features for conversion showed pathognomonic patterns that were distinctly different for the neovascular and the atrophic pathways. Predictive hallmarks for CNV were mostly drusen-centric, while GA markers were associated with neurosensory retina and age. CONCLUSIONS: Artificial intelligence with automated analysis of imaging biomarkers allows personalized prediction of AMD progression. Moreover, pathways of progression may be specific in respect to the neovascular/atrophic type.
引用
- Schmidt-Erfurth U, Waldstein SM, Klimscha S, et al. Prediction of Individual Disease Conversion in Early AMD Using Artificial Intelligence. Invest Ophthalmol Vis Sci. 2018. PMID: 29971444. doi:10.1167/iovs.18-24106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。